Protein structure-based protein language models
US-11538555-B1 · Dec 27, 2022 · US
US12080426B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12080426-B2 |
| Application number | US-202117217082-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 30, 2021 |
| Priority date | Apr 6, 2020 |
| Publication date | Sep 3, 2024 |
| Grant date | Sep 3, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Various examples of methods and systems are provided related to functional deep neural networks (FDNNs), which can be used for high dimensional data analysis. In one example, a FDNN can be trained with a training set of omic data to produce a trained FDNN model. The likelihood of a condition can be determined based upon output indications of the FDNN corresponding to the one or more phenotypes, with the output indications based upon analysis of omic data including a multi-level omic profile from an individual by the trained FDNN. The FDNN model can include a series of basis functions as layers to capture complexity between the omic data with disease phenotypes. A treatment or prevention strategy for the individual can be identified based at least in part upon the likelihood of the condition.
Opening claim text (preview).
Therefore, at least the following is claimed: 1. A method for risk prediction using high-dimensional omic data, comprising: training, by at least one computing device, a functional deep neural network (FDNN) with a training set of omic data to produce a trained FDNN model, the trained FDNN model comprising a series of basis functions as a plurality of layers that capture complexity between the omic data with disease phenotypes after training, the training set of omic data comprising biomarkers applied as inputs to the FDNN and one or more phenotypes, the trained FDNN model configured to provide output indications in a standardized format; obtaining, by the at least one computing device, omic data corresponding to an individual, the omic data comprising a multi-level omic profile from the individual stored in a database; determining, by the at least one computing device, a likelihood of a condition associated with a disease based upon output indications of the FDNN corresponding to the one or more phenotypes, the output indications based upon analysis of the omic data comprising the multi-level omic profile from the individual by the trained FDNN; identifying, by the at least one computing device, a treatment for the individual based at least in part upon the likelihood of the condition; and generating, by the at least one computing device, an indication of the treatment for rendering on a networked computing device, the indication of treatment transmitted to all authorized medical or clinical personnel over a network for real time access via networked computing devices. 2. The method of claim 1 , wherein a first layer of the plurality of layers comprises a univariate function and remaining layers of the plurality of layers comprise a bivariate function. 3. The method of claim 1 , wherein the training set of omic data comprises risk predictors related to the one or more phenotypes, the risk predictors including biomarkers or established risk predictors. 4. The method of claim 3 , wherein the one or more phenotypes comprise disease diagnostic assessments, multiple correlated phenotypes, or high-dimensional phenotypes. 5. The method of claim 4 , wherein the high-dimensional phenotypes comprise biomarkers or neuroimaging data. 6. The method of claim 1 , wherein the plurality of layers of the FDNN are built via functional linear models with functional coefficients as weights in individual layers. 7. The method of claim 6 , wherein the plurality of layers of the FDNN adopts a penalty on a second-order derivative of the basis functions to ensure smoothness of the basis functions. 8. The method of claim 1 , wherein weights and biases in the FDNN are functions, and the FDNN takes an integral of functional coefficients in individual layers. 9. A system for risk prediction using high-dimensional omic data, comprising: at least one computing device comprising processing circuitry including a processor and memory; and a FDNN analysis program that, when executed by the processing circuitry, cause the at least one computing device to: obtain an omic profile of an individual, the omic profile comprising a multi-level omic profile from the individual stored in a database; determining a likelihood of a condition associated with a disease based upon output indications of a functional deep neural network (FDNN) corresponding to one or more phenotypes, the output indications based upon analysis of omic data comprising the multi-level omic profile by the FDNN, where the FDNN was trained with a training set of omic data to produce a trained FDNN model, the trained FDNN model comprising a series of basis functions as a plurality of layers that capture complexity between the omic data with disease phenotypes, the trained FDNN model configured to provide the output indications in a standardized format; providing a treatment identified for the individual based at least in part upon the likelihood of the condition; and generating an indication of the treatment for rendering on a networked computing device or another computing device, the indication of treatment transmitted to all authorized medical or clinical personnel over a network for real time access via networked computing devices. 10. The system of claim 9 , wherein the training set of omic data comprising biomarkers applied as inputs to the FDNN and the one or more phenotypes. 11. The system of claim 10 , wherein the training set of omic data comprises risk predictors related to the one or more phenotypes, the risk predictors including biomarkers or established risk predictors. 12. The system of claim 11 , wherein the one or more phenotypes comprise disease diagnostic assessments, multiple correlated phenotypes, or high- dimensional phenotypes. 13. The system of claim 12 , wherein the high-dimensional phenotypes comprise multi-level omic or neuroimaging data. 14. The system of claim 9 , wherein a first layer of the plurality of layers comprises a univariate function and remaining layers of the plurality of layers comprise a bivariate function. 15. The system of claim 9 , wherein the plurality of layers of the FDNN are built via functional linear models with functional coefficients as weights in individual layers. 16. The system of claim 15 , wherein the plurality of layers of the FDNN adopts a penalty on a second-order derivative of the basis functions to ensure smoothness of the basis functions. 17. The system of claim 9 , wherein weights and biases in the FDNN are functions, and the FDNN takes an integral of functional coefficients in individual layers.
Feedforward networks · CPC title
Supervised learning · CPC title
for processing medical images, e.g. editing · CPC title
Artificial neural networks [ANN] · CPC title
Training; Learning · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.